C. Keser et al., THROMBOPROPHYLAXIS WITH LOW-DOSE HEPARIN (FRACTIONATED OR UNFRACTIONATED) - A CONTRAINDICATION TO SPINAL EPIDURAL ANESTHESIA/, Anasthesist, 45(12), 1996, pp. 1203-1210
Spinal or intracranial haematoma is a rare but severe complication of
spinal/epidural anaesthesia with an incidence of less than 1:100 000.
Co-agulation defects, traumatic puncture, and anticoagulant drugs are
assumed to be risk factors for the development of this kind of haemato
ma. Whether the risk of bleeding after spinal/epidural anaesthesia is
increased by the administration of low-dose heparin (unfractionated or
fractionated) for thromboprophylaxis is currently under discussion. M
ethods and results. A randomised, prospective trial answering this que
stion is not feasible because of the rarity of the complication. As an
alternative, we identified all case reports described in the literatu
re to date and analysed them for possible risk factors. In conjunction
with spinal/epidural anaesthesia, we found 4 cases of spinal and 2 ca
ses of intracranial haematoma following treatment with unfractionated
heparin and 6 cases of spinal haematoma following treatment with diffe
rent low-molecular-weight (LMW) heparins. In none of these cases could
thromboprophylaxis with heparin be identified as the only risk factor
for bleeding: in 11 of the 12 cases a difficult or traumatic puncture
was described. Eleven patients showed three or more possible risk fac
tors, e.g., coagulation defects, concomitant therapy with other antico
agulant drugs, or anatomic abnormalities. Conclusion. We suggest that
the development of spinal or intracranial haematoma after spinal/epidu
ral anaesthesia is a multifactorial event. An influence of low-dose he
parin prophylaxis as a cofactor cannot wholly be excluded because of t
he difficulty of studying thp problem in a prospective way. The few ca
se reports have to be seen in the context of millions of patients who
have received either unfractionated or LMW heparin and lumbar or thora
cic regional anaesthesia without any complication. We conclude that lo
w-dose heparin prophylaxis (fractionated or unfractionated) is not a d
efinite contraindication to spinal/epidural anaesthesia. High-risk (AS
A III/IV) patients in particular benefit from effective postoperative
analgesia achieved by local anaesthetics in combination with effective
heparin thromboprophylaxis. Nevertheless, the absolute contraindicati
ons for regional anaesthesia must be respected and an individual risk/
benefit analysis should be performed for every patient. An adequate ti
me interval between application of heparin and regional anaesthesia or
removal of a spinal/epidural catheter, atraumatic puncture technique,
and careful neurologic monitoring during the post-operative period ca
n minimise the risk of complications.